ASH 10-K Annual Report Sept. 30, 2024 | Alphaminr
ASHLAND GLOBAL HOLDINGS INC
ALPHAMINR

ASH 10-K Fiscal year ended Sept. 30, 2024

Balance Sheet
Cash Flow
Income Statement
Debt
ASHLAND GLOBAL HOLDINGS INC
TABLE OF CONTENTS
Part IItem 1. BusinessItem 1A. Risk FactorsItem 1A. RItem 1B. Unresolved Staff CommentsItem 1B. UnresolvItem 1C. CybersecurityItem 2. PropertiesItem 3. Legal ProceedingsItem 3. LegaItem 4. Mine Safety DisclosuresItem 4. Mine SafPart IIItem 5. Market For Registrant S Common Equity, Related Stockholder Matters and Issuer Purchases Of Equity SecuritiesItem 6. [reserved]Item 7. Management S Discussion and Analysis Of Financial Condition and Results Of OperationsItem 7A. Quantitative and Qualitative Disclosures About Market RiskItem 8. Financial Statements and Supplementary DataItem 9. Changes in and Disagreements with Accountants on Accounting and Financial DisclosureItem 9A. Controls and ProceduresItem 9B. Other InformationItem 9C. Disclosure Regarding Foreign Jurisdictions That Prevent InspectionsPart IIIItem 10. Directors, Executive Officers and Corporate GovernanceItem 10. Directors, Executive OfItem 11. Executive CompensationItem 11. ExecutItem 12. Security Ownership Of Certain Beneficial Owners and Management and Related Stockholder MattersItem 12. Security Ownership Of Certain Beneficial OwItem 13. Certain Relationships and Related Transactions, and Director IndependenceItem 13. Certain Relationships and RelateItem 14. Principal Accountant Fees and ServicesItem 14. Principal AccouPart IVItem 15. Exhibits and Financial Statement SchedulesItem 15. Exhibits and FinItem 16. Form 10-k SummaryItem 16. ForItem 7. Management S Discussion and Analysis OfItem 7A. Quantitative and QualitaItem 8. Financial Stateme

Exhibits

2.1 Stock and Asset Purchase Agreement, dated as of February 18, 2014, between Ashland Inc. and CD&R Seahawk Bidco, LLC (filed as Exhibit 2.1 to Ashlands Form 8-K filed on February 24, 2014 (SEC File No. 001-32532), and incorporated herein by reference). 2.2 Sale and Purchase Agreement related to the ASK Chemicals Group, dated April 8, 2014, among Ashland Inc., Ashland International Holdings, Inc., Clariant Produkte (Deutschland) GmbH, Clariant Corp., mertus 158. GmbH, Ascot US Bidco Inc. and Ascot UK Bidco Limited (filed as Exhibit 2.1 to Ashlands Form 8-K filed on April 14, 2014 (SEC File No. 001-32532), and incorporated herein by reference). 2.3 Agreement and Plan of Merger dated May 31, 2016, by and among Ashland Inc., Ashland Global Holdings Inc. and Ashland Merger Sub Corp. (filed as Exhibit 2.1 to Ashlands Form 8-K filed on May 31, 2016 (SEC File No. 001-32532), and incorporated herein by reference). 2.4 Stock and Asset Purchase Agreement, dated November 14, 2018, between Ashland Global Holdings Inc. and INEOS Enterprises Holdings Limited (pursuant to Item 601(b)(2) of Regulation S-K, exhibits, schedules and certain annexes to the Stock and Asset Purchase Agreement have been omitted; exhibits, schedules and annexes will be supplementally provided to the SEC upon request) (filed as Exhibit 2.1 to Ashlands Form 8-K filed on November 20, 2018 (SEC File No. 333-211719), and incorporated herein by reference.) 2.5 First Amendment to Stock and Asset Purchase Agreement, dated July 1, 2019, between Ashland Global Holdings Inc. and INEOS Enterprises Holdings Limited (pursuant to Item 601(b)(2) of Regulation S-K, exhibits, schedules and certain annexes to the Stock and Asset Purchase Agreement have been omitted; exhibits, schedules and annexes will be supplementally provided to the SEC upon request) (filed as Exhibit 2.1 to Ashlands Form 8-K filed on July 8, 2019 (SEC File No. 333-211719) and incorporated herein by reference). 2.6 Second Amendment to Stock and Asset Purchase Agreement, dated July 30, 2019, between Ashland Global Holdings Inc. and INEOS Enterprises Holdings Limited (pursuant to Item 601(b)(2) of Regulation S-K, exhibits, schedules and certain annexes to the Stock and Asset Purchase Agreement have been omitted; exhibits, schedules and annexes will be supplementally provided to the SEC upon request (filed as Exhibit 2.1 to Ashlands Form 8-K filed on August 2, 2019 (SEC File No. 333-211719) and incorporated herein by reference). 2.7 Asset Purchase Agreement dated July 25, 2020, by and between Ashland LLC and AOC Materials LLC (filed as Exhibit 2.1 to Ashlands Form 8-K filed on July 27, 2020 (SEC File No. 333-211719 and incorporated herein by reference). 2.8 Master Asset Purchase Agreement, dated January 18, 2021, entered into by and between Schlke & Mayr GmbH, ISP Marl Holdings and Ashland Industries Europe GmbH (filed as Exhibit 2.1 to Ashlands Form 8-K filed on January 22, 2021 (SEC File No.333-211719) and incorporated herein by reference). 2.9 Amendment Agreement to the Master Purchase Agreement regarding the acquisition of the Personal Care Business of Schlke & Mayr GmbH dated April 29, 2021, filed as Exhibit 2.2 to Ashlands Form 10-Q filed on July 29, 2021 (SEC File No.333-211719) and incorporated herein by reference). 2.10 Purchase and Sale Agreement, dated as of August 30, 2021, between Ashland LLC and Arkema, filed as Exhibit 2.1 to Ashlands Form 8-K filed on August 31, 2021 (SEC File No.333-211719) and incorporated herein by reference). 2.11 Amendment No. 1 to the Purchase and Sale Agreement, dated as of February 28, 2022, by and between Arkema and Ashland LLC (filed as Exhibit 2.1 to Ashlands Form 8-K filed on February 28, 2022 (SEC File No.333-211719) and incorporated herein by reference). 2.12 Stock Purchase Agreement, dated April 14, 2017, by and among Ashland LLC, Pharmachem Laboratories, Inc., the holders of common stock of Pharmachem Laboratories, Inc., Dr. David Peele, and Photon SH Representative LLC, solely as the shareholders representative (filed as Exhibit 2.1 to Ashlands Form 8-K filed on May 18, 2017 (SEC File No. 333-211719) and incorporated herein by reference). 2.13 Amendment No. 1 to the Stock Purchase Agreement, dated May 16, 2017, by and among Ashland LLC, Pharmachem Laboratories, Inc., the holders of common stock of Pharmachem Laboratories, Inc., Dr. David Peele, and Photon SH Representative LLC, solely as the shareholders representative (filed as Exhibit 2.2 to Ashlands Form 8-K filed on May 18, 2017 (SEC File No. 333-211719) and incorporated herein by reference). 2.14 Amendment No. 2 to the Stock Purchase Agreement, dated August 23, 2017, by and among Ashland LLC, Pharmachem Laboratories, Inc., the holders of common stock of Pharmachem Laboratories, Inc., Dr. David Peele, and Photon SH Representative LLC, solely as the shareholders representative (filed as Exhibit 10.84 to Ashlands Form 10-K for the fiscal year ended September 30, 2017 (SEC File No. 333-211719), and incorporated by reference herein). 3.1 Amended and Restated Articles of Incorporation of Ashland Global Holdings Inc. (filed as Exhibit 3.1 to Ashlands Form 8-K filed on September 20, 2016 (SEC File No. 001-32532)) and incorporated by reference herein). 3.2 Certificate of Ownership & Merger, amending the Companys Amended and Restated Certificate of Incorporation (filed as Exhibit 3.1 to Ashlands Form 8-K filed on August 1, 2022 (SEC File No. 001-32532) and incorporated by reference herein). 3.3 By-laws of Ashland Inc. (Amended and Restated as of September 20, 2022) (filed as Exhibit 3.1 to Ashlands Form 8-K filed on September 20, 2022 (SEC File No. 333-211719) and incorporated by reference herein). 4.1 Indenture, dated as of February 26, 2013, between Ashland Inc. and U.S. Bank National Association, as Trustee (filed as Exhibit 4.3 to Ashlands Form 8-K filed on February 27, 2013 (SEC File No. 001- 32532), and incorporated herein by reference). 4.2 First Supplemental Indenture, dated as of February 26, 2013, between Ashland Inc. and U.S. Bank National Association, as Trustee, in respect of the senior notes due 2016, 2018 and 2043 (filed as Exhibit 4.4 to Ashlands Form 8-K filed on February 27, 2013 (SEC File No. 001-32532), and incorporated herein by reference). 4.3 Second Supplemental Indenture, dated as of March 14, 2013, between Ashland Inc. and U.S. Bank National Association, as Trustee, in respect of the senior notes due 2043 (filed as Exhibit 4.2 to Ashlands Form 8-K filed on March 18, 2013 (SEC File No. 001-32532), and incorporated herein by reference). 4.4 First Supplemental Indenture as of August 1, 2022, to the Trust Indenture in respect of the 2031 Notes dated as of August 18, 2021, by and among Ashland Global Holdings Inc. (now Ashland Inc.), U.S. Bank Trust Company, National Association, as trustee (filed as Exhibit 4.12 to Ashland's Form 10-K for the fiscal year ended September 30, 2022, filed on November 21, 2022 (SEC File No. 333-211719), and incorporated herein by reference). 4.5 Third Supplemental Indenture dated October 19, 2016, among Ashland LLC, Ashland Global Holdings Inc. and US Bank National Association, to the Indenture dated as of February 26, 2013 between Ashland LLC and US Bank National Association (filed as Exhibit 4.2 to Ashlands Form 8-K filed on October 20, 2016 (SEC File No. 333-211719), and incorporated herein by reference). 4.6 Fourth Supplemental Indenture dated August 1, 2022, to the Trust Indenture dated as of February 26, 2013, between Ashland Global Holdings Inc. (now Ashland Inc.) and U.S. Bank Trust Company, National Association, as trustee (filed as Exhibit 4.14 to Ashland's Form 10-K for the fiscal year ended September 30, 2022, filed on November 21, 2022 (SEC File No. 333-211719), and incorporated herein by reference). 4.7 Indenture dated January 23, 2020, among Ashland Services B.V., Ashland Global Holdings Inc., Ashland LLC and U.S. Bank National Association, as trustee, in respect of the Senior Euro-Denominated Notes due 2028 (filed as Exhibit 4.1 to Ashlands Form 8-K filed on January 23, 2020 (SEC File No. 333-211719) and incorporated herein by reference). 4.8(a) Description of Capital Stock (filed as Exhibit 4.14(a) to Ashlands Form 10-K for the fiscal year ended September 30, 2019 (SEC File No. 333-211719) and incorporated herein by reference). 4.8(b) Description of 6.875% Senior Notes due 2043 (filed as Exhibit 4.14(b) to Ashlands Form 10-K for the fiscal year ended September 30, 2019 (SEC File No. 333-211719) and incorporated herein by reference). 4.8(c)** Description of 3.75% Senior Notes due 2031, filed herewith. 4.9 Indenture dated August 18, 2021, among Ashland LLC, Ashland Global Holdings Inc. and U.S. Bank National Association, as trustee, in respect of the Notes due 2031 (filed as Exhibit 4.1 to Ashlands Form 8-K filed on August 18, 2021 (SEC File No. 333-211719), and incorporated herein by reference). 10.1 Amended and Restated Ashland Inc. Deferred Compensation Plan for Non-Employee Directors (2005) (filed as Exhibit 10.4 to Ashlands Form 10-K for the fiscal year ended September 30, 2008 (SEC File No. 001-32532), and incorporated herein by reference). 10.2 Amendment to the Amended and Restated Ashland Inc. Deferred Compensation Plan for Non-Employee Directors (2005) (filed as Exhibit 10.4 to Ashlands Form 10-Q for the quarter ended March 31, 2015 (SEC File No. 001-32532), and incorporated herein by reference). 10.3 Amended and Restated Ashland Global Holdings Inc. Deferred Compensation Plan for Non-Employee Directors (2005) effective as of January 1, 2017 (filed as Exhibit 10.4 to Ashlands Form 10-Q for the quarter ended December 31, 2016 (SEC File No. 333-211719), and incorporated herein by reference). 10.4 Amended and Restated Ashland Inc. Deferred Compensation Plan for Employees (2005) (filed as Exhibit 10.3 to Ashlands Form 10-K for the fiscal year ended September 30, 2008 (SEC File No. 001-32532) and incorporated herein by reference). 10.5 Ashland Global Holdings Inc. Deferred Compensation Plan for Employees (Amended and Restated Effective as of May 22, 2019) (filed as Exhibit 10.1 to Ashlands Form10-Q for the quarter ended June 30, 2019 (SEC File No. 333-211719), and incorporated herein by reference). 10.6 Ashland Global Holdings Inc. Deferred Compensation Plan for Non-Employee Directors (Amended and Restated as of May 22, 2019) (filed as Exhibit 10.2 to Ashlands Form 10-Q for the quarter ended June 30, 2019 (SEC File No. 333-21179), and incorporated herein by reference). 10.7 Ashland Supplemental Defined Contribution Plan for Certain Employees (filed as Exhibit 10.3 to Ashlands Form 10-Q for the quarter ended March 31, 2011 (SEC File No. 001-32532), and incorporated herein by reference) (Frozen). 10.8 Amended and Restated 2011 Ashland Inc. Incentive Plan (filed as Exhibit 10.2 to Ashlands Form 8-K filed on February 1, 2013 (SEC File No. 001-32532), and incorporated herein by reference). 10.9 Amended and Restated 2015 Ashland Global Holdings Inc. Incentive Plan (filed as Exhibit 10.21 to Ashlands Form 10-K for the fiscal year ended September 30, 2016 (SEC File No. 333-211719), and incorporated by reference herein). 10.10 Form of Stock Appreciation Rights Award Agreement under the Amended and Restated 2011 Ashland Inc. Incentive Plan (filed as Exhibit 10.16 to Ashlands Form 10-K for the fiscal year ended September 30, 2014 (SEC File No. 001-32532), and incorporated herein by reference). 10.11 Form of Stock Appreciation Rights Award Agreement under the Amended and Restated 2015 Ashland Global Holdings Inc. Incentive Plan (Double-Trigger Form) (filed as Exhibit 10.39 to Ashlands Form 10-K for the fiscal year ended September 30, 2016 (SEC File No. 333-211719), and incorporated by reference herein). 10.12 Form of Indemnification Agreement between Ashland and members of its Board of Directors (filed as Exhibit 10.2 to Ashlands Form 8-K filed on September 20, 2016 (SEC File No. 333-211719), and incorporated herein by reference). 10.13 Form of Cash-Settled Performance Unit (LTIP) Award Agreement under the Amended and Restated 2015 Ashland Global Holdings Inc. Incentive Plan (Double-Trigger Form) (filed as Exhibit 10.59 to Ashlands Form 10-K for the fiscal year ended September 30, 2016 (SEC File No. 333-211719), and incorporated by reference herein). 10.14 Amended and Restated Hercules Deferred Compensation Plan effective January 1, 2008 (filed as Exhibit 10.8 to Ashlands Form 10-K for the fiscal year ended on September 30, 2010 (SEC File No. 001-32532), and incorporated herein by reference). 10.15 Amendment to the Amended and Restated Hercules Deferred Compensation Plan dated September 30, 2016 (annuity cash-out) (filed as Exhibit 10.61 to Ashlands Form 10-K for the fiscal year ended September 30, 2016 (SEC File No. 333-211719), and incorporated by reference herein). 10.16 Ashland Global Holdings Inc. 2018 Omnibus Incentive Compensation Plan (filed as Exhibit 10.1 to Ashlands Form 8-K filed on January 26, 2018 (SEC File No. 333-211719), and incorporated herein by reference). 10.17 Form of Stock-Settled Restricted Stock Unit Award Agreement under the Ashland Global Holdings Inc. 2018 Omnibus Incentive Compensation Plan (filed as Exhibit 10.2 to Ashlands Form 8-K filed on January 26, 2018 (SEC File No. 333-211719), and incorporated herein by reference). 10.18 Form of Restricted Stock Award Agreement under the Ashland Global Holdings Inc. 2018 Omnibus Incentive Compensation Plan (filed as Exhibit 10.3 to Ashlands Form 8-K filed on January 26, 2018 (SEC File No. 333-211719), and incorporated herein by reference). 10.19 Form of Stock Appreciation Rights Award Agreement under the Ashland Global Holdings Inc. 2018 Omnibus Incentive Compensation Plan (filed as Exhibit 10.4 to Ashlands Form 8-K filed on January 26, 2018 (SEC File No. 333-211719), and incorporated herein by reference). 10.20 Form of Performance Unit Award Agreement under the Ashland Global Holdings Inc. 2018 Omnibus Incentive Compensation Plan (filed as Exhibit 10.5 to Ashlands Form 8-K filed on January 26, 2018 (SEC File No. 333-211719), and incorporated herein by reference). 10.21 Form of Cash-Settled Restricted Stock Unit Award Agreement under the Ashland Global Holdings Inc. 2018 Omnibus Incentive Compensation Plan (filed as Exhibit 10.6 to Ashlands Form 8-K filed on January 26, 2018 (SEC File No. 333-211719), and incorporated herein by reference). 10.22 Ashland Global Holdings Inc. NonQualified Defined Contribution Plan (Amended and Restated as of May 22, 2019) (filed as Exhibit 10.3 to Ashlands Form 10-Q for the quarter ended June 30, 2019 (SEC File No. 333-211719), and incorporated herein by reference). 10.23 Ashland Global Holdings Inc. Supplemental Defined Contribution Plan for Certain Employees (Amended and Restated as of May 22, 2019) (filed as Exhibit 10.39 to Ashlands Form 10-K filed on November 25, 2019 (SEC File No. 333-211719) and incorporated herein by reference). 10.24 Form of Restricted Stock Award Agreement under the Ashland Global Holdings Inc. 2018 Omnibus Incentive Compensation Plan (with pro-rata vesting upon death, disability and retirement) (filed as Exhibit 10.5 to Ashlands Form 10-Q for the quarter ended June 30, 2019 (SEC File No. 333-211719), and incorporated herein by reference). 10.25 Form of Stock Appreciation Rights Award Agreement (Stock Settled) under the Ashland Global Holdings Inc. 2018 Omnibus Incentive Compensation Plan (with pro-rata vesting upon death, disability and retirement) (filed as Exhibit 10.6 to Ashlands Form 10-Q for the quarter ended June 30, 2019 (SEC File No. 333-211719), and incorporated herein by reference). 10.26 Form of Restricted Stock Unit Award Agreement under the Ashland Global Holdings Inc. 2018 Omnibus Incentive Compensation Plan (with pro-rata vesting upon death, disability and retirement) (filed as Exhibit 10.7 to Ashlands Form 10-Q for the quarter ended June 30, 2019 (SEC File No. 333-211719), and incorporated herein by reference). 10.27 Form of Stock-Settled Performance Unit Award Agreement under the Ashland Global Holdings Inc. 2018 Omnibus Incentive Compensation Plan (with pro-rata vesting upon death, disability and retirement) (filed as Exhibit 10.8 to Ashlands Form 10-Q for the quarter ended June 30, 2019 (SEC File No. 333-211719), and incorporated herein by reference). 10.28 Offer Letter dated as of October 8, 2019, entered into by Guillermo Novo and Ashland Global Holdings Inc. (filed as Exhibit 10.1 to Ashlands Form 8-K filed on October 8, 2019 (SEC File No. 333-211719) and incorporated herein by reference). 10.29 Ashland Global Holdings Inc. 2021 Omnibus Incentive Compensation Plan (filed as Exhibit 10.1 to Ashlands Form 8-K filed on February 3, 2021 (SEC File No. 333-211719) and incorporated herein by reference). 10.30 Form of Stock-Settled Restricted Stock Unit Award Agreement (filed as Exhibit 10.2 to Ashlands Form 8-K filed on February 3, 2021 (SEC File No. 333-211719) and incorporated herein by reference). 10.31 Form of Restricted Share Award Agreement (filed as Exhibit 10.3 to Ashlands Form 8-K filed on February 3, 2021 (SEC File No. 333-211719) and incorporated herein by reference). 10.32 Form of Stock Appreciation Rights Award Agreement (filed as Exhibit 10.4 to Ashlands Form 8-K filed on February 3, 2021 (SEC File No. 333-211719) and incorporated herein by reference). 10.33 Form of Performance Unit Award Agreement (filed as Exhibit 10.5 to Ashlands Form 8-K filed on February 3, 2021 (SEC File No. 333-211719) and incorporated herein by reference). 10.34 Form of Cash-Settled Restricted Stock Unit Award Agreement (filed as Exhibit 10.6 to Ashlands Form 8-K filed on February 3, 2021 (SEC File No. 333-211719) and incorporated herein by reference). 10.35 Form of Cash Settled Restricted Stock Equivalent Award Agreement for Non-U.S. Participants under the Ashland Global Holdings Inc. 2021 Omnibus Incentive Compensation Plan (filed as Exhibit 10.2 to Ashlands Form 8-K filed on August 6, 2021 (SEC File No. 333-211719) and incorporated herein by reference). 10.36 Form of Cash Settled Performance Unit Award Agreement for Non-U.S. Participants under the Ashland Global Holdings Inc. 2021 Omnibus Incentive Compensation Plan (filed as Exhibit 10.3 to Ashlands Form 8-K filed on August 6, 2021 (SEC File No. 333-211719) and incorporated herein by reference). 10.37 Form of Stock Settled Performance Unit Agreement for U.S. Employees under the Ashland Global Holdings Inc. 2021 Omnibus Incentive Compensation Plan (filed as Exhibit 10.4 to Ashlands Form 8-K filed on August 6, 2021 (SEC File No. 333-211719) and incorporated herein by reference). 10.38 Form of Restricted Stock Unit Agreement for U.S. Employees under the Ashland Global Holdings Inc. 2021 Omnibus Incentive Compensation Plan (filed as Exhibit 10.5 to Ashlands Form 8-K filed on August 6, 2021 (SEC File No. 333-211719) and incorporated herein by reference). 10.39 Form of Stock-Settled Performance Unit Agreement for (Germany) under the Ashland Global Holdings Inc. 2021 Omnibus Incentive Compensation Plan (filed as Exhibit 10.6 to Ashlands Form 8-K filed on August 6, 2021 (SEC File No. 333-211719) and incorporated herein by reference). 10.40 Form of Restricted Stock Unit Agreement for (Germany) under the Ashland Global Holdings Inc. 2021 Omnibus Incentive Compensation Plan (filed as Exhibit 10.7 to Ashlands Form 8-K filed on August 6, 2021 (SEC File No. 333-211719) and incorporated herein by reference). 10.41 Form of Chief Executive Officer Change in Control Agreement (filed as Exhibit 10.69 to Ashland's Form 10-K for the fiscal year ended September 30, 2021, filed on November 22, 2021 (SEC File No. 333-211719), and incorporated by reference herein. 10.42 Ashland Inc. Senior Leadership Severance Plan (effective as of September 19, 2022) filed as Exhibit 10.60 to Ashland's Form 10-K for the fiscal year ended September 30, 2022, filed on November 21, 2022 (SEC File No. 333-211719), and incorporated by reference herein. 10.43 Form of Stock-Settled Performance Unit Agreement for US Employees, effective as of September 19, 2022 under the Ashland Global Holdings Inc. 2021 Omnibus Incentive Compensation Plan filed as Exhibit 10.61 to Ashland's Form 10-K for the fiscal year ended September 30, 2022, filed on November 21, 2022 (SEC File No. 333-211719), and incorporated by reference herein. 10.44 Form of Cash-Settled Performance Unit (PSU) Award Agreement for Non-US Participants, effective as of September 19, 2022 under the Ashland Global Holdings Inc. 2021 Omnibus Incentive Compensation Plan filed as Exhibit 10.62 to Ashland's Form 10-K for the fiscal year ended September 30, 2022, filed on November 21, 2022 (SEC File No. 333-211719), and incorporated by reference herein. 10.45 Form of Restricted Stock Unit (RSU) Award Agreement for US Participants, effective as of September 19, 2022 under the Ashland Global Holdings Inc. 2021 Omnibus Incentive Compensation Plan filed as Exhibit 10.63 to Ashland's Form 10-K for the fiscal year ended September 30, 2022, filed on November 21, 2022 (SEC File No. 333-211719), and incorporated by reference herein. 10.46 Form of Cash-Settled Restricted Equivalent (RSE) Award Agreement for Non-US Participants, effective as of September 19, 2022 under the Ashland Global Holdings Inc. 2021 Omnibus Incentive Compensation Plan filed as Exhibit 10.64 to Ashland's Form 10-K for the fiscal year ended September 30, 2022, filed on November 21, 2022 (SEC File No. 333-211719), and incorporated by reference herein. 10.47 Amendment No. 1 effective as of November 17, 2022, to the Ashland Global Holdings Inc. Deferred Compensation Plan for Non-Employee Directors (Amended and Restated as of May 2019) filed as Exhibit 10.65 to Ashland's Form 10-K for the fiscal year ended September 30, 2022, filed on November 21, 2022 (SEC File No. 333-211719), and incorporated by reference herein. 10.48 Ashland Inc. Independent Director Deferred Compensation Program effective as of November 17, 2022 filed as Exhibit 10.66 to Ashland's Form 10-K for the fiscal year ended September 30, 2022, filed on November 21, 2022 (SEC File No. 333-211719), and incorporated by reference herein. 10.49 Form of Restricted Stock Unit Agreement (Independent Directors), effective as of November 17, 2022 filed as Exhibit 10.67 to Ashland's Form 10-K for the fiscal year ended September 30, 2022, filed on November 21, 2022 (SEC File No. 333-211719), and incorporated by reference herein. 10.50 Credit Agreement dated as of January 10, 2020, among Ashland Global Holdings Inc., Ashland Chemco Inc., Ashland LLC, Ashland Services B.V., each lender from time to time party thereto, the Bank of Nova Scotia, as administrative agent, swing line lender and a letter of credit issuer, each other letter of credit issuer from time to time party thereto and Citibank, N.A., as syndication agent (filed as Exhibit 10.1 to Ashlands Form 8-K filed on January 10, 2020 (SEC File No. 333-211719) and incorporated herein by reference). 10.51 Amended and Restated Credit Agreement dated as of July 22, 2022, among Ashland Global Holdings Inc., Ashland Chemco Inc., Ashland LLC, Ashland Services B.V., each lender from time to time party thereto, the Bank of Nova Scotia, Houston Branch, as administrative agent, swing line lender and a letter of credit issuer, each other letter of credit issuer from time to time party thereto and Citibank, N.A., as syndication agent (filed as Exhibit 10.1 to Ashlands Form 8-K filed on July 22, 2022 (SEC File No. 333-211719) and incorporated herein by reference). 10.52 Second Amended and Restated Purchase and Sale Agreement, dated March 17, 2021, by and among Ashland LLC and Ashland Specialty Ingredients G.P., as originators, Ashland LLC, as initial servicer, and CVG Capital III LLC, as purchaser (filed as Exhibit 10.1 to Ashlands Form 8-K filed on March 18, 2021 (SEC File No. 333-211719) and incorporated herein by reference). 10.53 Receivables Purchasing Agreement, dated March 17, 2021, by and among CVG Capital III LLC, PNC Bank, National Association, as administrative agent, PNC Bank Capital Markets LLC, as structuring agent, Ashland LLC, as initial servicer, and certain other persons from time to time party thereto (filed as Exhibit 10.2 to Ashlands Form 8-K filed on March 18, 2021 (SEC File No. 333-211719) and incorporated herein by reference). 10.54 First Amendment as of February 22, 2022, to the Receivables Purchase Agreement dated March 17, 2021, by and among CVG Capital III LLC, PNC Bank, National Association, as administrative agent, Ashland LLC, as initial servicer, and certain other persons identified as Purchasers, LC, LC Participants and Group Agents and other persons from time to time identified as parties thereto (filed as Exhibit 10.1 to Ashlands Form 8-K filed on February 28, 2022 (SEC File No. 333-211719) and incorporated herein by reference). 10.55 Assignment Agreement dated February 22, 2022, between CVG Capital III LLC and Ashland LLC (filed as Exhibit 10.2 to Ashlands Form 8-K filed on February 28, 2022 (SEC File No. 333-211719) and incorporated herein by reference). 10.56 First Amendment as of August 1, 2022, to the Second Amended and Restated Purchase and Sale Agreement, dated March 17, 2021, by and among Ashland Inc. as an originator and servicer, and Ashland Specialty Ingredients G.P., as originator, and CVG Capital III LLC, as purchaser filed as Exhibit 10.74 to Ashland's Form 10-K for the fiscal year ended September 30, 2022, filed on November 21, 2022 (SEC File No. 333-211719), and incorporated by reference herein. 10.57 Second Amendment as of August 1, 2022, to the Receivables Purchase Agreement dated March 17, 2021, by and among CVG Capital III LLC, PNC Bank, National Association, as administrative agent, Ashland Inc. in its individual capacity and as initial servicer, and certain other persons identified as Purchasers, LC, LC Participants and Group Agents and other persons from time to time identified as parties thereto filed as Exhibit 10.75 to Ashland's Form 10-K for the fiscal year ended September 30, 2022, filed on November 21, 2022 (SEC File No. 333-211719), and incorporated by reference herein. 10.58 Assumption Agreement dated September 20, 2016, by and between Ashland Global Holdings Inc. and Ashland Inc. (filed as Exhibit 10.1 to Ashlands Form 8-K filed on September 20, 2016 (SEC File No. 333-211719), and incorporated herein by reference). 10.59 Separation Agreement dated as of September 22, 2016, between and among Ashland Global Holdings Inc. and Valvoline Inc. (filed as Exhibit 10.1 to Ashlands Form 8-K filed on September 28, 2016 (SEC File No. 333-211719), and incorporated herein by reference). 10.60 Tax Matters Agreement dated as of September 22, 2016, between and among Ashland Global Holdings Inc. and Valvoline Inc. (filed as Exhibit 10.4 to Ashlands Form 8-K filed on September 28, 2016 (SEC File No. 333-211719), and incorporated herein by reference). 10.61 Employee Matters Agreement dated as of September 22, 2016, between and among Ashland Global Holdings Inc. and Valvoline Inc. (filed as Exhibit 10.5 to Ashlands Form 8-K filed on September 28, 2016 (SEC File No. 333-211719), and incorporated herein by reference). 10.62 Master Confirmation - Uncollared Accelerated Share Repurchase, dated September 2, 2021, between Ashland Global Holdings Inc. and JPMorgan Chase Bank, National Association (filed as Exhibit 10.1 to Ashlands Form 8-K filed on September 7, 2021 (SEC File No. 333-211719), and incorporated herein by reference). 10.63 Amendment dated November 22, 2021 to the Master Confirmation (as supplemented by the Supplemental Confirmation) Uncollared Accelerated Share Repurchase September 2, 2021, between Ashland Global Holdings Inc. and JPMorgan Chase Bank, National Association (filed as Exhibit 10.1 to Ashlands Form 10-Q filed on February 3, 2022 (SEC File No. 333-211719), and incorporated herein by reference). 10.64 Fourth Amendment to the Receivables Purchase Agreement dated as of September 13, 2024 by and among Ashland, Ashland Specialty Ingredients G.P., a Delaware general partnership, CVG Capital III LLC, a bankruptcy-remote special purpose entity and subsidiary of Ashland, PNC Bank, National Association, as administrative agent, PNC Capital Markets LLC, as structuring agent, Ashland, as initial servicer, and certain other persons from time to time named as parties thereto as purchasers, group agents, LC banks and LC participants (filed as Exhibit 10.1 to Ashlands Form 8-K filed on September 16, 2024 (SEC File No. 333-211719), and incorporated herein by reference). 10.65** Form of Restricted Stock Unit Agreement pursuant to Ashland Inc.s 2021 Omnibus Incentive Compensation Plan, filed herewith. 10.66** Form of Cash-Settled Restricted Stock Equivalent Agreement for Non-U.S. Participants pursuant to Ashland Inc.s 2021 Omnibus Incentive Compensation Plan, filed herewith. 10.67** Form of Stock-Settled Performance Unit Agreement pursuant to Ashland Inc.s 2021 Omnibus Incentive Compensation Plan, filed herewith. 10.68** Form of Cash-Settled Performance Unit Agreement for Non-U.S. Participants pursuant to Ashland Inc.s 2021 Omnibus Incentive Compensation Plan, filed herewith. 19.1** Insider Trading Policy. 21** List of Subsidiaries. 23.1** Consent of Ernst & Young LLP. 23.2** Consent of Gnarus Advisors LLC. 24** Power of Attorney. 31.1** Certification of Guillermo Novo, Chief Executive Officer of Ashland, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. 31.2** Certification of J. Kevin Willis, Chief Financial Officer of Ashland, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. 32** Certification of Guillermo Novo, Chief Executive Officer of Ashland, and J. Kevin Willis, Chief Financial Officer of Ashland, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. 97** Ashland, Inc. Dodd-Frank Compensation Recoupment Policy.